Remission of relapsed leukaemia during a graft-versus-host reaction. A "graft-versus-leukaemia reaction" in man?
about
T Cell Receptor Excision Circle (TREC) Monitoring after Allogeneic Stem Cell Transplantation; a Predictive Marker for Complications and Clinical OutcomeMolecular matching in allogeneic bone marrow transplantation.A history of haemopoietic cell transplantation.Post-transplant immunotherapy designed to prevent cancer recurrence.Role of donor lymphocyte infusions in relapsed hematological malignancies after stem cell transplantation revisitedAllogeneic bone marrow transplantation with reduced conditioning (RC-BMT).NCI First International Workshop on the Biology, Prevention, and Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation: Report from the Committee on Treatment of Relapse after Allogeneic Hematopoietic Stem Cell TransplantatioUnrelated donor leukocyte infusions to treat relapse after unrelated donor bone marrow transplantation.Wilms' Tumour 1 (WT1) peptide vaccination in patients with acute myeloid leukaemia induces short-lived WT1-specific immune responses.Adoptive cellular therapy: a therapeutic reality?Nonablative hematopoietic cell transplantation for the treatment of metastatic renal cell carcinoma.'GVHD': graft-versus-host disease or graft-versus-Hodgkin's disease? An old acronym with new meaning.Nonengraftment haploidentical cellular therapy for hematologic malignancies.Sustained disease-free survival achieved with withdrawal of immunosuppression after rapid relapse of myelodysplastic syndrome following myeloablative allogeneic hematopoietic transplantation: a case report.Autografting as first line treatment for chronic myeloid leukaemia.Genetically engineered donor T cells to optimize graft-versus-tumor effects across MHC barriers.Review of allogeneic hematopoietic stem cell transplantation with reduced intensity conditioning in solid tumors excluding breast cancer.The allogeneic graft-versus-cancer effect.Challenges in T cell receptor gene therapy.Pushing the envelope-nonmyeloablative and reduced intensity preparative regimens for allogeneic hematopoietic transplantation.Feasibility of low-dose interleukin-2 therapy following T-cell-depleted nonmyeloablative allogeneic hematopoietic stem cell transplantation from HLA-matched or -mismatched family member donors.Number of treatment cycles influences development of cytotoxic T cells in metastatic breast cancer patients - a phase I/II study.Tumor burden influences cytotoxic T cell development in metastatic breast cancer patients--a phase I/II study.Response and toxicity of donor lymphocyte infusions following T-cell depleted non-myeloablative allogeneic hematopoietic SCT from 3-6/6 HLA matched donors.Graft-versus-leukemia reactions in clinical bone marrow transplantation.Graft-versus-leukemia effect and its clinical implications.Adoptive immunotherapy for relapsed leukemia following allogeneic bone marrow transplantation.Reduced risk of recurrent leukaemia in bone marrow transplant recipients after cytomegalovirus infection.Anti-leukaemic role of acute GvHD after unrelated haematopoietic stem cell transplantation in intermediate- to high-risk acute myelogenous leukaemia.Donor leukocyte transfusions for treatment of leukemic relapse after bone marrow transplantation. EBMT Immunology and Chronic Leukemia Working Parties.Changes in antibiotic sensitivity in strains of Staphylococcus aureus, 1952-78.Genetically enhanced T lymphocytes and the intensive care unit.
P2860
Q28072227-5257F713-2910-480A-83F1-82963C45203BQ33539331-F589F7CA-275A-4F8D-BF83-0190E8CA3763Q33610841-158B2F02-6823-436C-9FE2-D1176D47679DQ33788224-5A595E5C-8FAD-46ED-93FF-60E3932B8406Q34065058-F0F46088-1949-487D-A480-108670B9CD8DQ34135678-ADE1148E-0EE2-4F4E-AC76-64C76771539CQ34202277-A214225A-DB59-4A66-8FB5-A3995D9D8AA4Q34573989-C6C3DC94-751D-4D5B-9660-3AAEB9322B68Q34617770-5B95016B-4264-4892-9450-AAB5B919D830Q34875170-907BEFFB-1E43-4A0B-9EB0-EB7FA743E6C2Q35022491-69214F9F-AA42-41C8-988F-670F9AC81448Q35122185-A8AF54BD-295F-4569-B563-1039A1D25419Q35725927-D23479E7-A9FF-4B3F-82A5-8C461728EA95Q36581381-8CDBC2C5-2D4F-4203-971E-9D3CBCE2FDEFQ37217601-6BA968AA-5AF5-4BFD-AE40-DF89131E398DQ37416883-CFBEAAD8-8BF9-4C12-95A9-BBA9FB8EE5D6Q37522583-1BEB5E8F-1A9F-4D6A-8303-AA1AAAE4F359Q37593125-AF04E18B-6737-4862-82E5-815F4FD70D88Q38011650-8396CDBC-6B0F-40BD-8DCC-214ABE5DE9EFQ38488058-6BEDBA07-FC07-478D-AB1E-BC5B504847F1Q39669347-7451F469-BCBA-41D5-947A-17C688F4815FQ39676770-BB76407D-2F71-416F-B74F-D42B87A4136CQ39783015-66D9AE5D-32F5-4463-B16E-655F03CF4DA9Q40094506-B7225597-A9FF-4110-9BE8-D6C6D69458C1Q40860389-FF717694-6C25-4018-8D2A-2BF601A2A3C5Q40920988-76134FB6-0EFE-4FE5-888A-E2B2ACBF5D80Q40958061-59B8AFEE-63DB-4998-A7B3-FCEC2A1443AAQ43714651-2F406079-5C0B-4638-A749-33E74C430433Q46961778-71E543CA-C52E-4C03-A0EF-4882DB04A1E0Q47686713-CDFD541E-4F25-473C-8844-6B1B3E470A25Q55114235-AD31568A-A2C9-4A75-A7D7-CE1F0EA6B0DEQ55380614-7957B20D-F965-43E3-B749-D2CD0C161269
P2860
Remission of relapsed leukaemia during a graft-versus-host reaction. A "graft-versus-leukaemia reaction" in man?
description
1978 nî lūn-bûn
@nan
1978年の論文
@ja
1978年学术文章
@wuu
1978年学术文章
@zh-cn
1978年学术文章
@zh-hans
1978年学术文章
@zh-my
1978年学术文章
@zh-sg
1978年學術文章
@yue
1978年學術文章
@zh
1978年學術文章
@zh-hant
name
Remission of relapsed leukaemi ...... us-leukaemia reaction" in man?
@en
Remission of relapsed leukaemi ...... us-leukaemia reaction" in man?
@nl
type
label
Remission of relapsed leukaemi ...... us-leukaemia reaction" in man?
@en
Remission of relapsed leukaemi ...... us-leukaemia reaction" in man?
@nl
prefLabel
Remission of relapsed leukaemi ...... us-leukaemia reaction" in man?
@en
Remission of relapsed leukaemi ...... us-leukaemia reaction" in man?
@nl
P2093
P1433
P1476
Remission of relapsed leukaemi ...... us-leukaemia reaction" in man?
@en
P2093
C S August
F B Johnson
J H Githens
J R Humbert
S L Rusnak
P304
P356
10.1016/S0140-6736(78)92879-9
P407
P577
1978-09-01T00:00:00Z